Australia Scraps Covid-19 Vaccine That Produced H.I.V. False Positives

213 0
Australia Scraps Covid-19 Vaccine That Produced H.I.V. False Positives

Australia on Friday canceled a roughly $ 750 million plan for a major order for a locally developed coronavirus vaccine after vaccination led to false positive test results for H.I.V. for some volunteers taking part in an experimental study.

Of the dozen of coronavirus vaccines tested around the world, the Australian one was the first to be abandoned. While the developers said the experimental vaccine was safe and effective, the false positives risked confidence in efforts to vaccinate the public.

Prime Minister Scott Morrison said Friday that his government would partially offset the loss of 51 million doses it planned to buy from the Australian consortium by increasing orders for vaccines from AstraZeneca and Novavax. The government has announced that it will start vaccinating citizens in March.

"We can't have problems with trust," he told reporters, "and now as a nation with a good portfolio of vaccines we are able to make those choices to best protect the Australian people."

The Australian setback highlighted the missteps that can inevitably occur when scientists shorten the usual year-long process of vaccine development to a few months during a pandemic that killed more than 1.5 million people.

But just as the Australian scientists made their announcement, the fruits of this breed became clearer. The United States got one step closer to getting its first approval for a Covid-19 vaccine when a panel of experts advising the Food and Drug Administration endorsed a Pfizer vaccine that is already in use in the UK.

The problem that arose with the Australian vaccine developed by the University of Queensland and biotech company CSL was related to the use of two fragments of a protein found in H.I.V.

The protein was part of a molecular "bracket" that researchers placed on the spikes surrounding the coronavirus and allowed it to penetrate healthy cells. The bracket stabilizes the spikes and allows the immune system to respond more effectively to the vaccine.

The use of the H.I.V. Protein posed no risk of infecting the volunteers with this virus, the researchers said. However, the clamp generated the production of antibodies identified by H.I.V. Tests at higher levels than scientists expected.

Because H.I.V. The tests couldn't be quickly revised to take this into account. The researchers decided to stop developing the vaccine. The act could have created widespread fears among Australians that the vaccine could cause AIDS.

Early experiments on hamsters showed that the vaccine protected them from the coronavirus. When Phase 1 human trials began in July, the 216 volunteers were "fully informed about the possibility of a partial immune response" to the terminal, the University of Queensland and CSL said in a statement Friday.


Dec. 11, 2020, 8:17 p.m. ET

The mistake, said John P. Moore, an immunologist at Weill Cornell Medical College in New York, was an "honest mistake" that cost money, not human life.

"I'm sure a lot of people are very embarrassed," said Professor Moore. "It's not great to be associated with a mistake like this. But when you run at 90 mph, you sometimes trip."

The coronavirus outbreak>

Things to know about testing

Confused by Coronavirus Testing Conditions? Let us help:

    • antibody: A protein produced by the immune system that can recognize and attach to certain types of viruses, bacteria or other invaders.
    • Antibody test / serology test: A test that detects antibodies specific to the coronavirus. About a week after the coronavirus infects the body, antibodies start appearing in the blood. Because antibodies take so long to develop, an antibody test cannot reliably diagnose an ongoing infection. However, it can identify people who have been exposed to the coronavirus in the past.
    • Antigen test: This test detects parts of coronavirus proteins called antigens. Antigen tests are quick and only take five minutes. However, they are less accurate than tests that detect genetic material from the virus.
    • Coronavirus: Any virus that belongs to the Orthocoronavirinae virus family. The coronavirus that causes Covid-19 is known as SARS-CoV-2.
    • Covid19: The disease caused by the new coronavirus. The name stands for Coronavirus Disease 2019.
    • Isolation and quarantine: Isolation is separating people who know they have a contagious disease from those who are not sick. Quarantine refers to restricting the movement of people who have been exposed to a virus.
    • Nasopharyngeal smear: A long, flexible rod with a soft swab that is inserted deep into the nose to collect samples from the space where the nasal cavity meets the throat. Samples for coronavirus tests can also be obtained with swabs that do not go as deep into the nose – sometimes called nasal swabs – or with mouth or throat swabs.
    • Polymerase chain reaction (PCR): Scientists use PCR to make millions of copies of genetic material in a sample. With the help of PCR tests, researchers can detect the coronavirus even when it is scarce.
    • Viral load: The amount of virus in a person's body. In people infected with the coronavirus, viral loads can peak before symptoms, if any.

The University of Queensland vaccine was one of several vaccines under development that contain a coronavirus protein that triggers an immune system response. Protein-based vaccines have a longer track record than some of the newer approaches used by competing coronavirus vaccines, such as those based on viral genes or called adenoviruses.

Prominent protein-based vaccines include one from Novavax of Maryland, which is in Phase 3 trials, and another from Clover Biopharmaceuticals of China, which is in Phase 1.

In the case of the Australian vaccine, it was found to produce a strong immune response and, according to the scientists in the phase 1 study, did not cause any serious side effects. However, proceeding with the vaccine trial would have "significant changes" in the longstanding H.I.V. Testing procedures, they said.

"This would delay development for another 12 months, and while this is a difficult decision, the urgent need for a vaccine must be everyone's priority," Paul Young, a virologist at the university who directed the vaccine effort, said in the Explanation. He did not immediately respond to a request for comment on Friday afternoon.

Australian Health Secretary Greg Hunt told reporters the country still has access to 140 million units of coronavirus vaccines – more than enough to feed its population of approximately 25 million people.

"This is the scientific process that works," said Hunt. "It's the planning process that works. It's an honest explanation for some of the challenges we've faced."

Carl Zimmer contributed to the reporting.

Leave a Reply